{"url":"https://lda.senate.gov/api/v1/filings/643de136-669c-4db2-936e-8bd81a1309ef/","filing_uuid":"643de136-669c-4db2-936e-8bd81a1309ef","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2022,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/643de136-669c-4db2-936e-8bd81a1309ef/print/","filing_document_content_type":"text/html","income":"10000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Katina Pierce","dt_posted":"2023-01-19T11:49:10-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"600 Maryland Avenue, SW","registrant_address_2":"SUITE 220E","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20024","registrant":{"id":8511,"url":"https://lda.senate.gov/api/v1/registrants/8511/","house_registrant_id":31321,"name":"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.","description":"Consultant firm","address_1":"600 Maryland Avenue SW","address_2":"Suite 220E","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20024","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"KATINA PIERCE","contact_telephone":"+1 202-484-1100","dt_updated":"2026-07-07T12:11:18.019485-04:00"},"client":{"id":53384,"url":"https://lda.senate.gov/api/v1/clients/53384/","client_id":53384,"name":"VHL ALLIANCE","general_description":"federal research funding for von Hippel-Lindau (VHL) disease.","client_government_entity":null,"client_self_select":false,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-11-01"},"lobbying_activities":[{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"HR 2617, PL 117-328, Consolidated Appropriations Act, Fiscal year 2023, DoD research on Von Hippel-Lindau syndrome","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":32743,"prefix":null,"prefix_display":null,"first_name":"MARK","nickname":null,"middle_name":null,"last_name":"VIETH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"HR 2617, PL 117-328, Consolidated Appropriations Act, Fiscal year 2023, DoD research on Von Hippel-Lindau syndrome","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":32743,"prefix":null,"prefix_display":null,"first_name":"MARK","nickname":null,"middle_name":null,"last_name":"VIETH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}